Stable IgG-antibody levels in patients with mild SARS-CoV-2 infection

Thomas Åkerlund, Katherina Zakikhany, Charlotta Löfström, Evelina Lindmark, Henrik Källberg, Ulla Elofsson, Karin Cederbrant, Erik Nygren, Anders Kallin, Nina Lagerqvist, Peter Nilsson, Sophia Hober, Anna Ridderstad Wollberg, Åsa Szekely Björndal
doi: https://doi.org/10.1101/2021.06.16.21258960

Article Information

doi 
https://doi.org/10.1101/2021.06.16.21258960
History 
  • June 18, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Thomas Åkerlund1,*,
  2. Katherina Zakikhany1,
  3. Charlotta Löfström2,
  4. Evelina Lindmark2,
  5. Henrik Källberg1,
  6. Ulla Elofsson2,
  7. Karin Cederbrant2,
  8. Erik Nygren2,
  9. Anders Kallin2,
  10. Nina Lagerqvist1,
  11. Peter Nilsson3,
  12. Sophia Hober3,
  13. Anna Ridderstad Wollberg2 and
  14. Åsa Szekely Björndal1
  1. 1Public Health Agency of Sweden, Solna, Sweden
  2. 2RISE Research Institutes of Sweden, Borås, Sweden
  3. 3KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
  1. ↵*Corresponding author: Thomas Åkerlund, Department of Microbiology, Public Health Agency of Sweden, Solna Sweden; email: thomas.akerlund{at}folkhalsomyndigheten.se; telephone;+46102052467
Back to top
Posted June 18, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Stable IgG-antibody levels in patients with mild SARS-CoV-2 infection
Thomas Åkerlund, Katherina Zakikhany, Charlotta Löfström, Evelina Lindmark, Henrik Källberg, Ulla Elofsson, Karin Cederbrant, Erik Nygren, Anders Kallin, Nina Lagerqvist, Peter Nilsson, Sophia Hober, Anna Ridderstad Wollberg, Åsa Szekely Björndal
medRxiv 2021.06.16.21258960; doi: https://doi.org/10.1101/2021.06.16.21258960
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area